Skip to main content
. 2020 Feb 15;59(7):927–939. doi: 10.1007/s40262-020-00862-6
This is the first study to demonstrate the major cytochrome P450 2D6 dependency of the clearance of yohimbine.
Yohimbine as a potential probe drug for cytochrome P450 2D6 activity can also be used in a microdose setting to minimise the risk for any potential study population.
HHS Vulnerability Disclosure